Archer Daniels Midland 8-K

PositiveEarningsGuidance raised

Stronger crushing and ethanol margins drive FY2026 adjusted EPS guidance up to ≈$5.15–$5.60.

Filed 2026-08-04 06:03 ET

Summary

Q2 2026 results with raised FY2026 adjusted EPS guidance. Growth across ADM’s segments was driven by strong crushing and ethanol margins in a constructive biofuels environment, alongside Flavors-led momentum in Nutrition. FY2026 adjusted EPS guidance rose to approximately $5.15–$5.60 from $4.15–$4.70, reflecting expected improvement in crushing and ethanol and continued progress in Nutrition.

Key Figures

Metric Q2 2026 H1 2026
Revenue $22.7B, +7% Y/Y $43.2B, +4% Y/Y
Gross margin (GAAP) 8.53%, vs 6.47% 7.31%, vs 6.17%
Earnings before income taxes (GAAP) $1.09B, +290% Y/Y $1.47B, +133% Y/Y
Total segment operating profit (non-GAAP) $1.45B, +75% Y/Y $2.21B, +40% Y/Y
Net earnings attributable to ADM (GAAP) $908M, +315% Y/Y $1.21B, +135% Y/Y
Adjusted net earnings (non-GAAP) $895M, +98% Y/Y $1.24B, +57% Y/Y
Diluted EPS (GAAP) $1.87, +316% Y/Y $2.49, +135% Y/Y
Adjusted diluted EPS (non-GAAP) $1.84, +98% Y/Y $2.56, +57% Y/Y
Cash provided by operating activities — $1.30B, -67% Y/Y
  • Agriculture Services and Oilseeds operating profit rose 129% to $867M. Crushing profit was $363M vs $33M, supported by a better margin environment and oilseed volumes up approximately 5%; results included around $100M of net positive mark-to-market and timing impacts. Ag Services also benefited from the return to full operations of ADM’s Barcarena grain export terminal in Brazil and higher soybean exports.
  • Carbohydrate Solutions profit increased 22% to $411M as policy incentives and the RVO supported ethanol margins. Nutrition profit rose 51% to $172M, with Human Nutrition gains led by Flavors and progress at the Decatur East plant; Animal Nutrition also improved on operational gains and portfolio actions.
  • H1 operating cash flow was lower as working capital used $460M, versus providing $2.72B in H1 2025. Cash flows from operations before working capital, a non-GAAP cash-generation measure, were $1.8B vs $1.2B.

Guidance

Metric Period Guidance Prior Direction
Adjusted diluted EPS (non-GAAP) FY2026 ≈$5.15–$5.60 $4.15–$4.70 Raised
Capital expenditures FY2026 $1.3B–$1.5B — —
Guidance changes, derived from earlier filings
MetricPeriodEarlier guidanceGuidance nowChange
Adjusted diluted EPS (non-GAAP)FY2026≈$4.15-$4.70≈$5.15–$5.60raised
Capital expendituresFY2026$1.3B-$1.5B$1.3B–$1.5Breaffirmed

Investor Takeaways

  • Crushing and ethanol margins will test whether the constructive biofuels environment supports the expected earnings improvement in the second half; continued performance beyond Q2 crushing profit of $363M would support the raised outlook.
  • Nutrition’s follow-through, particularly Flavors and the Decatur East plant, will show whether the momentum behind its 51% Q2 profit growth continues.

Was this summary useful?

The summary is written by an AI model reading the filing.

Model 005 · prompt v173 · 2026-11-03 20:17:25Z

Feedback